Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Liquidia (NASDAQ:LQDA) through any online brokerage.
Other companies in Liquidia’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Liquidia has a consensus price target of $43.33.
The stock price for Liquidia (NASDAQ: LQDA) is $27.2854 last updated October 12, 2026 at 11:37 AM EDT.
There are no upcoming dividends for Liquidia.
Liquidia does not have any upcoming earnings scheduled.
There is no upcoming split for Liquidia.
Liquidia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.